Towards optimal patient selection for bronchial thermoplasty treatment in severe asthma: results from the TASMA randomized trial

A. Goorsenberg (Amsterdam, Netherlands), J. D'Hooghe (Amsterdam, Netherlands), N. Ten Hacken (Groningen, Netherlands), E. Weersink (Amsterdam, Netherlands), E. Bel (Amsterdam, Netherlands), P. Shah (London, United Kingdom), J. Annema (Amsterdam, Netherlands), P. Bonta (Amsterdam, Netherlands)

Source: International Congress 2019 – Clinical studies of asthma treatments
Session: Clinical studies of asthma treatments
Session type: Thematic Poster
Number: 2537
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Goorsenberg (Amsterdam, Netherlands), J. D'Hooghe (Amsterdam, Netherlands), N. Ten Hacken (Groningen, Netherlands), E. Weersink (Amsterdam, Netherlands), E. Bel (Amsterdam, Netherlands), P. Shah (London, United Kingdom), J. Annema (Amsterdam, Netherlands), P. Bonta (Amsterdam, Netherlands). Towards optimal patient selection for bronchial thermoplasty treatment in severe asthma: results from the TASMA randomized trial. 2537

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Efficacy of bronchial thermoplasty (BT) in patients with severe asthma: the AIR2 trial
Source: Annual Congress 2009 - Persistent asthma: still an uncontrolled disease requiring new treatments strategies in 2009
Year: 2009

A randomised clinical trial of feedback on inhaler adherence and technique in patients with severe uncontrolled asthma
Source: Eur Respir J, 51 (1) 1701126; 10.1183/13993003.01126-2017
Year: 2018



The effect of salt room treatment on bronchial hyperresponsiveness in asthmatics: a randomised controlled trial
Source: Eur Respir J 2005; 26: Suppl. 49, 505s
Year: 2005

Long-term asthma treatment guided by airway hyperresponsiveness in children: a randomised controlled trial
Source: Eur Respir J 2007; 30: 457-466
Year: 2007



Long-term efficacy of a home-based airway clearance programme to improve cough severity in patients with bronchiectasis:a randomised controlled trial>
Source: International Congress 2019 – Advances in bronchiectasis and non-TB mycobacterial infections
Year: 2019




Airway hyperresponsiveness to mannitol as a predictor of treatment response to ciclesonide in patients with suspected asthma: A double-blind, randomised, placebo-controlled trial
Source: Annual Congress 2012 - Bronchial challenge as a biomarker of respiratory disease
Year: 2012

A proof-of-concept randomized-controlled trial of omalizumab in patients with severe difficult to control nonatopic asthma
Source: Annual Congress 2012 - Clinical diagnosis and treatment of adult asthma
Year: 2012


Impact of bronchial thermoplasty on asthma status: interim results from the AIR trial
Source: Eur Respir J 2006; 28: Suppl. 50, 114s
Year: 2006

Can we predict response of refractory asthmatic cough to tiotropium? :a prospective study
Source: Virtual Congress 2020 – Chronic cough: only symptom or disease?
Year: 2020


Bronchial thermoplasty: a new therapeutic option for the treatment of severe, uncontrolled asthma in adults
Source: Eur Respir Rev 2014; 23: 510-518
Year: 2014



Inhaled corticosteroids in patients with mild to moderate COPD with and without airway hyperresponsiveness to mannitol: A randomized placebo controlled trial
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011


A randomized controlled study of omalizumab in children with moderate-to-severe persistent allergic asthma
Source: Annual Congress 2008 - Drug therapy and assessment of control in childhood asthma
Year: 2008


A randomised controlled trial to investigate the optimal dose and effect of salbutamol for the treatment of acute exacerbations of COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 244s
Year: 2002

A systematic evaluation of the diagnostic criteria for COPD and exacerbations used in randomised controlled trials on the management of COPD exacerbations
Source: ERJ Open Res, 5 (4) 00136-2019; 10.1183/23120541.00136-2019
Year: 2019



ß-blockers in exacerbations of COPD: feasibility of a randomised controlled trial
Source: ERJ Open Res, 3 (1) 00090-2016; 10.1183/23120541.00090-2016
Year: 2017



STEP-UP randomized controlled trial of vapor ablation in patients with severe emphysema: 12 month results
Source: International Congress 2016 – Endoscopic lung volume reduction I
Year: 2016

A feasibility, randomised controlled trial of a complex breathlessness intervention in idiopathic pulmonary fibrosis (BREEZE-IPF): study protocol
Source: ERJ Open Res, 5 (4) 00186-2019; 10.1183/23120541.00186-2019
Year: 2019



Self-titration of inhaled corticosteroid and ß2-agonist in response to symptoms in mild asthma: a pre-specified analysis from the PRACTICAL randomised controlled trial
Source: Eur Respir J, 56 (4) 2000170; 10.1183/13993003.00170-2020
Year: 2020



Effects of aerobic exercise on asthma control in eosinophilic asthma patients: a randomized controlled trial
Source: International Congress 2018 – Clinical determinants of asthma and biomarkers
Year: 2018




Real-life effectiveness of omalizumab in patients with severe persistent allergic asthma: the PERSIST study
Source: Annual Congress 2009 - Towards improving asthma control
Year: 2009